0001654954-20-001650.txt : 20200214 0001654954-20-001650.hdr.sgml : 20200214 20200214181922 ACCESSION NUMBER: 0001654954-20-001650 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200212 FILED AS OF DATE: 20200214 DATE AS OF CHANGE: 20200214 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: NIFFENEGGER KATHI CENTRAL INDEX KEY: 0001620146 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37619 FILM NUMBER: 20622456 MAIL ADDRESS: STREET 1: C/O STELLAR BIOTECHNOLOGIES, INC. STREET 2: 332 EAST SCOTT STREET CITY: PORT HUENEME STATE: CA ZIP: 93041 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Edesa Biotech, Inc. CENTRAL INDEX KEY: 0001540159 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 0930 BUSINESS ADDRESS: STREET 1: 100 SPY COURT CITY: MARKHAM STATE: A6 ZIP: L3R 5H6 BUSINESS PHONE: (905) 475-1234 MAIL ADDRESS: STREET 1: 100 SPY COURT CITY: MARKHAM STATE: A6 ZIP: L3R 5H6 FORMER COMPANY: FORMER CONFORMED NAME: Stellar Biotechnologies, Inc. DATE OF NAME CHANGE: 20120120 4 1 section16.xml PRIMARY DOCUMENT X0306 4 2020-02-12 0001540159 Edesa Biotech, Inc. EDSA 0001620146 NIFFENEGGER KATHI C/O EDESA BIOTECH, INC. 100 SPY COURT MARKHAM A6 L3R 5H6 ONTARIO, CANADA true Chief Financial Officer Share Option (Right to Buy) 3.16 2020-02-12 4 A false 88699 0 A 2030-02-12 Common Shares 88699 88699 D 33% vested on 2/12/2020, with a prorata amount of the balance vesting monthly thereafter over the next 36 months until fully vested /s/ Kathi Niffenegger 2020-02-14